Should You Continue to Hold EXAS Stock in Your Portfolio Now? [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
In addition, EXAS' commercial capabilities are driving stronger Cologuard adoption, narrowing the screening gap. Yet, the fierce competitive landscape and macroeconomic challenges pose operational risks. Over the past year, this Zacks Rank #3 (Hold) stock has plunged 81.3% compared to the 19.1% growth of the industry. Meanwhile, the S&P 500 composite has risen 19.5% in the same time frame. The renowned global medical device company has a market capitalization of $19.34 billion. EXAS has an estimated long-term earnings growth rate of 30.3% compared with the industry's 22.1% growth. Its earnings surpassed estimates in each of the trailing four quarters, the average surprise being 352.3%. Let's delve deeper. Enhancing Customer Experience : Exact Sciences plans to transform cancer care by providing patients with valuable insights at every step of their diagnosis and treatment. The company is currently working to build the best digital infrastructure and diagnostics. This vision ha
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Is Exact Sciences (EXAS) Still Attractive After An 81% One Year Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned [Yahoo! Finance]Yahoo! Finance
- Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics [Seeking Alpha]Seeking Alpha
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 1/9/26 - Form DEFM14A
- 12/30/25 - Form 4
- 12/30/25 - Form 4
- EXAS's page on the SEC website